Mesenchymal Stem Cell Conditioned Medium as Good as Methyl Prednisolone in Decreasing Levels of Interleukin 10 and The Degree of Pulmonary Vasculitis in Lupus Mice
Background: Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has immunosuppressive, anti-inflammatory, and immunoregulatory properties in lupus. Methyl prednisolone is a standard drug for lupus with immunosuppressive an...
Saved in:
Published in | Bangladesh journal of medical science (Ibn Sina Trust) Vol. 20; no. 2; pp. 426 - 430 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Dhaka
Ibn Sina Trust
01.02.2021
|
Subjects | |
Online Access | Get full text |
ISSN | 2223-4721 2076-0299 |
DOI | 10.3329/bjms.v20i2.51560 |
Cover
Abstract | Background: Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has immunosuppressive, anti-inflammatory, and immunoregulatory properties in lupus. Methyl prednisolone is a standard drug for lupus with immunosuppressive and anti-inflammatory properties. This study aims to compare the therapeutic effect of mesenchymal stem cell conditioned medium administration compared to methyl prednisolone on interleukin 10 levels and the degree of pulmonary vasculitis of lupus mice.
Methods: The subjects were 24 female mice of Mus musculus Balb/C strain, which were categorized into 4 groups of 8 mice, i.e. the control group receiving 0.5 cc of 0.9% NaCl injection and placebo, the lupus group receiving 0.5 cc of pristane injection and placebo, and the treatment mesenchymal stem cell conditioned medium group receiving 0.5 cc pristane injection and mesenchymal stem cell conditioned medium 0,5 cc, and methylprednisolone group receiving 0,5 cc pristiane injection and methylprednisolone p.o 1,5 mg/kgbodyweight. After 24 days the mice were terminated and kidney and blood samples were taken. Statistical analysis was performed using ANOVA test followed by independent T-test. The p value was considered significant when the p < 0.05.
Results: The study showed that there was no difference on the levels of interleukin level10 among mesenchymal stem cell conditioned medium goup and methyl prednisolone group (CM = 5,94 ± 2,49 pg/mL, mp = 5,86+1,73 pg/mL; p = 1) and the degree of pulmonary vasculitis (CM= 1,94 ± 0,25, MP=1,89+ 0,11 pg/ml; p = 0.667). Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice.
Conclusion: Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice
Bangladesh Journal of Medical Science Vol.20(2) 2021 p.426-430 |
---|---|
AbstractList | Background:Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has immunosuppressive, anti-inflammatory, and immunoregulatory properties in lupus. Methyl prednisolone is a standard drug for lupus with immunosuppressive and anti-inflammatory properties. This study aims to compare the therapeutic effect of mesenchymal stem cell conditioned medium administration compared to methyl prednisolone on interleukin 10 levels and the degree of pulmonary vasculitis of lupus mice.Methods:The subjects were 24 female mice of Mus musculus Balb/C strain, which were categorized into 4 groups of 8 mice, i.e. the control group receiving 0.5 cc of 0.9% NaCl injection and placebo, the lupus group receiving 0.5 cc of pristane injection and placebo, and the treatment mesenchymal stem cell conditioned medium group receiving 0.5 cc pristane injection and mesenchymal stem cell conditioned medium 0,5 cc, and methylprednisolone group receiving 0,5 cc pristiane injection and methylprednisolone p.o 1,5 mg/kgbodyweight. After 24 days the mice were terminated and kidney and blood samples were taken. Statistical analysis was performed using ANOVA test followed by independent T-test. The p value was considered significant when the p < 0.05.Results:The study showed that there was no difference on the levels of interleukin level10 among mesenchymal stem cell conditioned medium goup and methyl prednisolone group (CM = 5,94 ± 2,49 pg/mL, mp = 5,86+1,73 pg/mL; p = 1) and the degree of pulmonary vasculitis (CM= 1,94 ± 0,25, MP=1,89+ 0,11 pg/ml; p = 0.667). Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice.Conclusion:Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice Background: Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has immunosuppressive, anti-inflammatory, and immunoregulatory properties in lupus. Methyl prednisolone is a standard drug for lupus with immunosuppressive and anti-inflammatory properties. This study aims to compare the therapeutic effect of mesenchymal stem cell conditioned medium administration compared to methyl prednisolone on interleukin 10 levels and the degree of pulmonary vasculitis of lupus mice. Methods: The subjects were 24 female mice of Mus musculus Balb/C strain, which were categorized into 4 groups of 8 mice, i.e. the control group receiving 0.5 cc of 0.9% NaCl injection and placebo, the lupus group receiving 0.5 cc of pristane injection and placebo, and the treatment mesenchymal stem cell conditioned medium group receiving 0.5 cc pristane injection and mesenchymal stem cell conditioned medium 0,5 cc, and methylprednisolone group receiving 0,5 cc pristiane injection and methylprednisolone p.o 1,5 mg/kgbodyweight. After 24 days the mice were terminated and kidney and blood samples were taken. Statistical analysis was performed using ANOVA test followed by independent T-test. The p value was considered significant when the p < 0.05. Results: The study showed that there was no difference on the levels of interleukin level10 among mesenchymal stem cell conditioned medium goup and methyl prednisolone group (CM = 5,94 ± 2,49 pg/mL, mp = 5,86+1,73 pg/mL; p = 1) and the degree of pulmonary vasculitis (CM= 1,94 ± 0,25, MP=1,89+ 0,11 pg/ml; p = 0.667). Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice. Conclusion: Mesenchymal stem cell conditioned medium as good as methyl prednisolone in decreasing levels of interleukin 10 and the degree of pulmonary vasculitis in lupus mice Bangladesh Journal of Medical Science Vol.20(2) 2021 p.426-430 |
Author | Werdiningsih, Yulyani Adnan, Zainal Arifin Prabowo, Nurhasan Agung Nurudhin, Arief Prasetyo, Kukuh |
Author_xml | – sequence: 1 givenname: Nurhasan Agung surname: Prabowo fullname: Prabowo, Nurhasan Agung – sequence: 2 givenname: Zainal Arifin surname: Adnan fullname: Adnan, Zainal Arifin – sequence: 3 givenname: Arief surname: Nurudhin fullname: Nurudhin, Arief – sequence: 4 givenname: Yulyani surname: Werdiningsih fullname: Werdiningsih, Yulyani – sequence: 5 givenname: Kukuh surname: Prasetyo fullname: Prasetyo, Kukuh |
BookMark | eNp1kU1rGzEQhkVxoK6Te4-CntfVh3elPRa3TQM2MeTjumilWVuuVnKl3YB_T_5otXFPhcxlBvG88w56P6GZDx4Q-kzJknNWf22PfVq-MGLZsqRlRT6gOSOiKgir61meGePFSjD6Ed2kdCS5KkLKWs7R6xYSeH0498rhhwF6vAbn8Dp4YwebXQzegrFjj1XCtyGYqW9hOJwd3kUw3qbgMoatx99BR1DJ-j3ewAu4hEOH7_wA0cH4OwOUYOUNfjxAZvcRYAJ2o-uDV_GMn1XSo8u2adq2GU9jtrIartFVp1yCm399gZ5-_nhc_yo297d362-bQnPKh6I2FWgoYcWpMKpmrexKkV8oFdRALbiUHUijSmJWol1J1bYlJwBci0opSvkCfbnsPcXwZ4Q0NMcwRp8tGyZZRaUUdZkpcqF0DClF6JpTtH2-v6GkmdJopjSatzSatzSypPpPou2gpu8dorLufeFf-jiU_w |
CitedBy_id | crossref_primary_10_1088_1755_1315_824_1_012058 crossref_primary_10_4028_p_7lJFTP |
ContentType | Journal Article |
Copyright | 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION 3V. 7RV 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH K9. KB0 M0S NAPCQ PHGZM PHGZT PIMPY PKEHL PPXIY PQEST PQQKQ PQUKI PRINS |
DOI | 10.3329/bjms.v20i2.51560 |
DatabaseName | CrossRef ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China |
DatabaseTitle | CrossRef Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea ProQuest Central (New) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) |
DatabaseTitleList | Publicly Available Content Database CrossRef |
Database_xml | – sequence: 1 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2076-0299 |
EndPage | 430 |
ExternalDocumentID | 10_3329_bjms_v20i2_51560 |
GroupedDBID | 7RV 7X7 8FI 8FJ AAYXX ABDBF ABUWG ACUHS ADBBV AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS BAWUL BCNDV BENPR BKEYQ BPHCQ BVXVI CCPQU CITATION DIK EBD EOJEC ESX FYUFA GROUPED_DOAJ GX1 HMCUK KQ8 MK0 NAPCQ OBODZ PHGZM PHGZT PIMPY PQQKQ PROAC RNS TUS UKHRP 3V. 7XB 8FK AZQEC DWQXO K9. M48 PKEHL PPXIY PQEST PQUKI PRINS |
ID | FETCH-LOGICAL-c313t-9d6ece5e4317da92b8f57ece1171de97388fe8da50d47b48abb530ee3c76aa113 |
IEDL.DBID | 7X7 |
ISSN | 2223-4721 |
IngestDate | Fri Jul 25 08:29:33 EDT 2025 Thu Apr 24 22:53:56 EDT 2025 Tue Jul 01 03:33:13 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 2 |
Language | English |
License | http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c313t-9d6ece5e4317da92b8f57ece1171de97388fe8da50d47b48abb530ee3c76aa113 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 |
OpenAccessLink | https://www.proquest.com/docview/2826188795?pq-origsite=%requestingapplication% |
PQID | 2826188795 |
PQPubID | 2040930 |
PageCount | 5 |
ParticipantIDs | proquest_journals_2826188795 crossref_primary_10_3329_bjms_v20i2_51560 crossref_citationtrail_10_3329_bjms_v20i2_51560 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-02-01 |
PublicationDateYYYYMMDD | 2021-02-01 |
PublicationDate_xml | – month: 02 year: 2021 text: 2021-02-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | Dhaka |
PublicationPlace_xml | – name: Dhaka |
PublicationTitle | Bangladesh journal of medical science (Ibn Sina Trust) |
PublicationYear | 2021 |
Publisher | Ibn Sina Trust |
Publisher_xml | – name: Ibn Sina Trust |
SSID | ssj0000600598 ssib008506666 |
Score | 2.1858687 |
Snippet | Background: Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has... Background:Systemic lupus erythematosus is a chronic autoimmune disease that affects target organs. mesenchymal stem cell conditioned medium has... |
SourceID | proquest crossref |
SourceType | Aggregation Database Enrichment Source Index Database |
StartPage | 426 |
SubjectTerms | Cytokines Lupus Phosphates Stem cells |
Title | Mesenchymal Stem Cell Conditioned Medium as Good as Methyl Prednisolone in Decreasing Levels of Interleukin 10 and The Degree of Pulmonary Vasculitis in Lupus Mice |
URI | https://www.proquest.com/docview/2826188795 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 2076-0299 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000600598 issn: 2223-4721 databaseCode: KQ8 dateStart: 20090101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2076-0299 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000600598 issn: 2223-4721 databaseCode: DOA dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: Academic Search Ultimate (EBSCO) customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 2076-0299 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000600598 issn: 2223-4721 databaseCode: ABDBF dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 2076-0299 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000600598 issn: 2223-4721 databaseCode: DIK dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 2076-0299 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000600598 issn: 2223-4721 databaseCode: GX1 dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 2076-0299 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000600598 issn: 2223-4721 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 2076-0299 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0000600598 issn: 2223-4721 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR3LbtNAcAWthLhUPEWhRHvgwmEbr9eP9QlB6EOoqSKgKDdrH2MRcOw0jpH6PfwoMxuHqpdebMkee62d8bwfjL1zSWF85iqhiywRSBSR0AqMsFJpSFTmtSE_5PQyO79KvszT-eBw64a0yh1PDIzat4585GM0DTKpaTT2h9W1oKlRFF0dRmg8ZPsSVRWi6nx-K06pG9tOPd9yZqq1DEPqUCqKBK2fbeRSqbgY21_L7vhPHC3i45Tqi-9KqruMOkif0yfsYFAb-cctnp-yB9A8Y4-mQ2D8Ofs7pSoi9_NmiVDfNrDkE6hrPmkpIk3NiDwn4H7JTcfP2tbTeQqIpZrP1uCbBdIggvFFwz8HTZJ8CPyCUoo63lY8eA5r6H8jgIy4aTxHCkNYtNeBAGZ9jVtk1jf8R0hupV5J9LaLftXjUsiPXrCr05Pvk3MxzF8QTkm1EYXPwEEKpGN4U8RWV2mOV6TMpYciV1pXoL1JI5_kNtHG2lRFAMrlmTFSqpdsr8FPf8W402CL3PlIeaCMVgsgqSY4rlxBVughG-_2unRDc3KakVGXaKQQdkrCThmwUwbsHLL3_59YbRtz3AN7tENfOfyiXXlLUK_vv_2GPY4pkSWkah-xvc26h7eoiWzsKJDbiO1_OrmcfR0Fex6PZ3P5D_jJ4LA |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF6VIgEXxFMtFNgDHDi48Xr9WB8QQiklpXFViRblZta7Ywg4dohjUH4Pd34jM35Q9dJbT5bs8UP-Pu3svBl7afxY29DkjopD30FSuI6SoJ1MSAW-DK3S5IdMTsLJuf9xFsy22N-hFobSKoc1sV2obWXIRz5C0yAUikZjv13-dGhqFEVXhxEaHS2OYfMbTbb6zdEB4vvK8w7fn40nTj9VwDFSyLUT2xAMBECa0-rYy1QeRHhGiEhYiCOpVA7K6sC1fpT5SmdZIF0AaaJQayEkPvcGu-lL16de_dHsQn1T97fBHOg0AdV2tkPxUAs7PlpbXaRUSi8eZd8X9f4vz517-wHVM1_WjJcVQ6vtDu-xu_02lb_reHWfbUH5gN1K-kD8Q_Ynoaol822zQKlPa1jwMRQFH1cUAafmR5aTcLPguuYfqsrSMQFkRcFPV2DLOXIexfi85AftzpV8FnxKKUw1r3LeeioLaH6ggHC5Li1HRqPs1xUACZw2BUKiVxv-uU2mpd5M9LRps2zwVbj-PWLn14LMY7Zd4qfvMG4UZHFkrCstUAZtBiCoBtnLTUxW7y4bDf86NX0zdJrJUaRoFBE6KaGTtuikLTq77PX_O5ZdI5ArZPcG-NJ-SajTCwI_ufryC3Z7cpZM0-nRyfFTdsejJJo2TXyPba9XDTzDXdA6e95Sj7Mv1831f0yIG20 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Mesenchymal+Stem+Cell+Conditioned+Medium+as+Good+as+Methyl+Prednisolone+in+Decreasing+Levels+of+Interleukin+10+and+The+Degree+of+Pulmonary+Vasculitis+in+Lupus+Mice&rft.jtitle=Bangladesh+journal+of+medical+science+%28Ibn+Sina+Trust%29&rft.au=Prabowo%2C+Nurhasan+Agung&rft.au=Adnan%2C+Zainal+Arifin&rft.au=Nurudhin%2C+Arief&rft.au=Werdiningsih%2C+Yulyani&rft.date=2021-02-01&rft.issn=2223-4721&rft.eissn=2076-0299&rft.volume=20&rft.issue=2&rft.spage=426&rft.epage=430&rft_id=info:doi/10.3329%2Fbjms.v20i2.51560&rft.externalDBID=n%2Fa&rft.externalDocID=10_3329_bjms_v20i2_51560 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2223-4721&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2223-4721&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2223-4721&client=summon |